The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment
- B Wilffert
- , AFY Al Hadithy
- , VJ Sing
- , G Matroos
- , HW Hoek
- , J van Os
- , R Bruggeman
- , JRBJ Brouwers
- , PN van Harten
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.